| [1] |
Katiyar SK, Matsui MS, Mukhtar H. Ultraviolet-B exposure of human skin induces cytochromes P450 1A1 and 1B1[J]. J Invest Dermatol,2000,114(2):328-333.
|
| [2] |
Villard PH, Sampol E, Elkaim JL,et al. Increase of CYP1B1 transcription in human keratinocytes and HaCaT cells after UV-B exposure[J]. Toxicol Appl Pharmacol,2002, 178(3):137-143.
|
| [3] |
Gonzalez MC, Marteau C, Franchi J, et al. Cytochrome P450 4A11 expression in human keratinocytes:effects of ultraviolet irradiation[J]. Br J Dermatol,2001,145(5):749-757.
|
| [4] |
Chandra D, Kale RK. Influence of gamma-rays on the mouse liver cytochrome P450 system and its modulation by phenothiazine drugs[J]. Int J Radiat Biol,1999,75(3):335-349.
|
| [5] |
Chung HC, Kim SH, Lee MG, et al. Mitochondrial dysfunction by gamma-irradiation accompanies the induction of cytochrome P450 2E1(CYP2E1) in rat liver[J]. Toxicology, 2001,161(1-2):79-91.
|
| [6] |
Goeptar AR, te Koppele JM, van Maanen JM, et al.One-electron reductive bioactivation of 2,3,5,6-tetramethylben-zoquinone by cytochrome P450[J].Biochem Pharmacol, 1992,43(2):343-352.
|
| [7] |
Patterson LH.Rationale for the use of aliphatic N-oxides of cytotoxic anthraquinones as prodrug DNA binding agents:a new class of bioreductive agent[J].Cancer Metastasis Rev,1993,12(2):119-134.
|
| [8] |
Raleigh SM, Wanogho E, Burke MD, et al.Rat cytochromes P450(CYP) specifically contribute to the reductive bioactivation of AQ4N, an alkylaminoanthraquinone-di-N-oxide anticancer prodrug[J].Xenobiotica,1999,29(11):1115-1122.
|
| [9] |
Patterson LH, Murray GI.Tumour cytochrome P450 and drug activation[J].Curr Pharm Des, 2002,8(15):1335-1347.
|